Alexander Hermani

发表

Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer

R. Grobholz, P. Angel, J. Hess, 2005, Clinical Cancer Research.

Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.

R. Grobholz, U. Abel, P. Angel, 2005, Human pathology.

S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.

D. Mayer, P. Tessier, S. Medunjanin, 2006, Experimental cell research.

Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

H. Werner, D. Mayer, S. Medunjanin, 2013, Cellular signalling.

Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.

D. Mayer, J. Grisouard, S. Medunjanin, 2007, Molecular endocrinology.

Glycogen Synthase Kinase-3 Interacts with and Phosphorylates Estrogen Receptor and Is Involved in the

D. Mayer, G. Rincke, J. Grisouard, 2005 .

Impact of PKCδ on estrogen receptor localization and activity in breast cancer cells

D. Mayer, S. Medunjanin, Alexander Hermani, 2005, Oncogene.

Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer

Rainer Grobholz, R. Grobholz, P. Angel, 2005, Clinical Cancer Research.

Glycogen Synthase Kinase-3 Interacts with and Phosphorylates Estrogen Receptor α and Is Involved in the Regulation of Receptor Activity*

D. Mayer, G. Rincke, Senad Medunjanin, 2005, Journal of Biological Chemistry.

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

V. Ehemann, D. Mayer, J. Grisouard, 2009, Endocrine-related cancer.

Impact of PKCdelta on estrogen receptor localization and activity in breast cancer cells.

D. Mayer, S. Medunjanin, Alexander Hermani, 2005, Oncogene.